BCHE and neoplasm: In advanced gastric cancer, reduced serum cholinesterase levels have been independently associated with poorer progression-free and overall survival, as well as diminished response to systemic chemotherapy, suggesting that cholinesterase may reflect not only nutritional status but also tumor-related inflammatory burden and host metabolic reserve in this disease [26].